Sweden · Delayed Price · Currency is SEK Xspray Pharma AB Statistics
Total Valuation
STO:XSPRAY has a market cap or net worth of SEK 1.07 billion. The enterprise value is 1.12 billion.
| Market Cap | 1.07B |
| Enterprise Value | 1.12B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XSPRAY has 41.74 million shares outstanding. The number of shares has increased by 14.24% in one year.
| Current Share Class | 41.74M |
| Shares Outstanding | 41.74M |
| Shares Change (YoY) | +14.24% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.97% |
| Owned by Institutions (%) | 35.75% |
| Float | 30.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.17 |
| PS Ratio | n/a |
| PB Ratio | 2.00 |
| P/TBV Ratio | 2.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.47 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.27 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.23.
| Current Ratio | 0.85 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -25.95 |
Financial Efficiency
Return on equity (ROE) is -41.77% and return on invested capital (ROIC) is -22.48%.
| Return on Equity (ROE) | -41.77% |
| Return on Assets (ROA) | -21.40% |
| Return on Invested Capital (ROIC) | -22.48% |
| Return on Capital Employed (ROCE) | -43.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -9.67M |
| Employee Count | 27 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -129,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.73% in the last 52 weeks. The beta is 0.59, so STO:XSPRAY's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -56.73% |
| 50-Day Moving Average | 42.49 |
| 200-Day Moving Average | 38.35 |
| Relative Strength Index (RSI) | 31.87 |
| Average Volume (20 Days) | 356,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -245.33M |
| Pretax Income | -251.48M |
| Net Income | -251.35M |
| EBITDA | -242.11M |
| EBIT | -245.33M |
| Earnings Per Share (EPS) | -7.05 |
Balance Sheet
The company has 73.81 million in cash and 125.68 million in debt, giving a net cash position of -51.87 million or -1.24 per share.
| Cash & Cash Equivalents | 73.81M |
| Total Debt | 125.68M |
| Net Cash | -51.87M |
| Net Cash Per Share | -1.24 |
| Equity (Book Value) | 535.45M |
| Book Value Per Share | 14.42 |
| Working Capital | -20.24M |
Cash Flow
In the last 12 months, operating cash flow was -213.32 million and capital expenditures -1,000, giving a free cash flow of -213.32 million.
| Operating Cash Flow | -213.32M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -213.32M |
| FCF Per Share | -5.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:XSPRAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.24% |
| Shareholder Yield | -14.24% |
| Earnings Yield | -23.43% |
| FCF Yield | -19.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |